STAAR Surgical appoints former CEO David Bailey as Chief Commercial Officer

STAAR SURGICAL CO

David Bailey named Chief Commercial Officer effective Sept 8, 2026; joins executive committee, reports to CEO Warren Foust.
Bailey was STAAR CEO 2001-2008 and President Intl Ops 2008-2011; raised $60M+, secured 2005 FDA ICL approval, led Asia launches.
Compensation: CHF 462,825 (~$575K) base, 60% target bonus, $850K RSU grant, $1.4M LTI award (50% options/50% RSUs).
Return aims to accelerate EVO ICL growth as laser refractive volumes decline globally; expansion into South/Southeast Asia, South America, Africa.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.